Lp(a): from CV risk marker to therapeutic target - PACE-CME

1-3 of 3

Lp(a) as therapeutic target - now and in the future
Lp(a) as therapeutic target - now and in the future
Lp(a): from CV risk marker to therapeutic target
Lp(a) as therapeutic target - now and in the future
Prof. Erik Stroes, MD
- Prof. Erik Stroes, MD
Understanding the increased CV risk of high Lp(a) levels
Understanding the increased CV risk of high Lp(a) levels
Lp(a): from CV risk marker to therapeutic target
Understanding the increased CV risk of high Lp(a) levels
Prof. Florian Kronenberg, MD
- Prof. Florian Kronenberg, MD
Why focus on Lp(a)?
Why focus on Lp(a)?
Lp(a): from CV risk marker to therapeutic target
Why focus on Lp(a)?
Prof. Naveed Sattar
- Prof. Naveed Sattar